Kunwar Shailubhai
Corporate Officer/Principal at Baruch S. Blumberg Institute
Kunwar Shailubhai active positions
Companies | Position | Start | End |
---|---|---|---|
Baruch S. Blumberg Institute | Corporate Officer/Principal | - | - |
Career history of Kunwar Shailubhai
Former positions of Kunwar Shailubhai
Companies | Position | Start | End |
---|---|---|---|
TIZIANA LIFE SCIENCES LTD | Chief Executive Officer | - | 31/07/2022 |
Chief Tech/Sci/R&D Officer | - | 31/07/2022 | |
Tiziana Life Sciences Ltd. (United Kingdom)
Tiziana Life Sciences Ltd. (United Kingdom) BiotechnologyHealth Technology Tiziana Life Sciences Ltd. engages in the development of therapies for neurodegenerative and lung diseases. Its clinical pipeline includes Foralumab, Anti IL-6R, and Milciclib. The company was founded by Gabriele Marco Antonio Cerrone on February 11, 1998 and is headquartered in London, the United Kingdom. | Director/Board Member | 31/12/2007 | 31/07/2022 |
Chief Executive Officer | 31/12/2007 | - | |
Chief Tech/Sci/R&D Officer | 31/12/2007 | 14/07/2022 | |
ACCUSTEM SCIENCES, INC. | Director/Board Member | - | 19/06/2022 |
OKYO PHARMA LIMITED | Director/Board Member | 05/07/2017 | 16/06/2021 |
ACTAVIA LIFE SCIENCES, INC. | Director/Board Member | 31/07/2016 | 22/12/2020 |
Chief Executive Officer | 20/04/2017 | 05/02/2020 | |
Independent Dir/Board Member | 31/07/2016 | 20/04/2017 | |
SYNERGY PHARMACEUTICALS INC | Chief Tech/Sci/R&D Officer | 30/06/2008 | 30/04/2017 |
Founder | 31/12/2000 | 30/04/2017 | |
Corporate Officer/Principal | 31/12/2000 | 30/06/2008 | |
Pawfect Foods, Inc. | Chief Tech/Sci/R&D Officer | - | 10/08/2008 |
Drug Discovery Facility
Drug Discovery Facility Pharmaceuticals: MajorHealth Technology Part of SCYNEXIS, Inc., Drug Discovery Facility provides research into drug-discovery processes. The company is based in Cambridge, UK. Drug Discovery Facility was acquired by SCYNEXIS, Inc. from Aventis Cropscience on October 02, 2001. | Corporate Officer/Principal | 31/12/2002 | 31/12/2007 |
░░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░ ░░░░ ░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
░░░░░░░░░░ ░░ ░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
Training of Kunwar Shailubhai
University of Baroda | Doctorate Degree |
University of Missouri | Masters Business Admin |
Statistics
International
United States | 9 |
United Kingdom | 4 |
India | 2 |
Operational
Corporate Officer/Principal | 5 |
Director/Board Member | 5 |
Chief Tech/Sci/R&D Officer | 4 |
Sectoral
Health Technology | 9 |
Consumer Services | 4 |
Retail Trade | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 4 |
---|---|
ACTAVIA LIFE SCIENCES, INC. | Health Technology |
OKYO PHARMA LIMITED | Health Technology |
ACCUSTEM SCIENCES, INC. | Health Technology |
TIZIANA LIFE SCIENCES LTD | Health Technology |
Private companies | 7 |
---|---|
Pawfect Foods, Inc. | Retail Trade |
Synergy Pharmaceuticals LLC
Synergy Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Synergy Pharmaceuticals LLC engages on the development and commercialization of novel gastrointestinal therapies. Its commercial product, plecanatide, is marketed under the trademark name TRULANCE, which seeks to treat adults with chronic idiopathic constipation and irritable bowel syndrome with constipation. The company was founded by Kunwar Shailubhai and is headquartered in New York, NY. | Health Technology |
Tiziana Life Sciences Ltd. (United Kingdom)
Tiziana Life Sciences Ltd. (United Kingdom) BiotechnologyHealth Technology Tiziana Life Sciences Ltd. engages in the development of therapies for neurodegenerative and lung diseases. Its clinical pipeline includes Foralumab, Anti IL-6R, and Milciclib. The company was founded by Gabriele Marco Antonio Cerrone on February 11, 1998 and is headquartered in London, the United Kingdom. | Health Technology |
Baruch S. Blumberg Institute | |
Active With Me, Inc.
Active With Me, Inc. Miscellaneous Commercial ServicesCommercial Services Active With Me, Inc. provides online resources that seamlessly offer travelers unique, highly relevant and user-friendly information on activity-based travel. Its listings will be provided for product and service providers of interest to the activity-based traveler. The company was founded on December 6, 2012 and is headquartered in Sarnia, Canada. | Commercial Services |
Drug Discovery Facility
Drug Discovery Facility Pharmaceuticals: MajorHealth Technology Part of SCYNEXIS, Inc., Drug Discovery Facility provides research into drug-discovery processes. The company is based in Cambridge, UK. Drug Discovery Facility was acquired by SCYNEXIS, Inc. from Aventis Cropscience on October 02, 2001. | Health Technology |
Callisto Pharmaceuticals, Inc.
Callisto Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Callisto Pharmaceuticals, Inc. is a development stage biopharmaceutical company. The company operates through two subsidiary companies: Pharmaceuticals, Inc and Callisto Research Labs, LLC. It focuses primarily on the development of drugs to treat gastrointestinal disorder and diseases and rheumatoid arthritis and develops novel therapeutics to treat cancer. The company was founded by Judson A. Cooper and Joshua D. Schein in 1996 and is headquartered in New York, NY. | Health Technology |
- Stock Market
- Insiders
- Kunwar Shailubhai
- Experience